FENC · Fennec Pharmaceuticals Inc. · Debt
$10.62
+0.47 (+4.63%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$355.93M
Shares
35.07M
Volume · Oct 27
93.19K
Avg daily vol (3M)
184.23K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Long-term debt, including current maturities | 2025-09-30 | USD 19,377,000 | 10-Q filed 2025-11-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1211583
CUSIP
31447P100
13F (30d)
17 filings
17 filers
Visit website
Investor relations